Delivery Order SPE2DB24D2205-SPE2DB25FEHVD
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,549.80 on July 29, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 30, 2025. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $1,025.26. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $24,960.51 with firm fixed pricing. This competitively awarded, non-set-aside contract is scheduled for completion by September 15, 2025, with performance of work occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,499.79 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Multaq 400 mg tablets (60-count units). This competitive award, with no set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of September 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) valued at $3,359.77, with an ultimate completion date of September 11, 2025. This competitive award, issued September 10, 2025, utilizes firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $3,241.33. This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation. AmerisourceBergen, a...
- The Defense Logistics Agency awarded a $12,999.58 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 29, 2025. As a child contract, this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,683.12 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on June 4, 2025, with completion scheduled for June 5, 2025. This competitive award, issued without set-aside designation, utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a contract ceiling value of $11,265.36. This firm fixed-price delivery order, which carries an ultimate completion date of August 28, 2025, represents a non-competitive set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...
- The Defense Logistics Agency awarded a $1,866.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract, with an ultimate completion date of July 24, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. This award involved no set-aside designation,...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHVDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Multaq 400 mg tablets (60-count) with a ceiling value of $38,737.23. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills a broad range of pharmaceutical and medical supply needs for military and veteran healthcare systems through its DLA contracts. The Multaq delivery order exemplifies the company's role in supplying specialty medications and brand-name drugs across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to consistently meet competitive procurement requirements and deliver diverse medical commodities ranging from small-value transactions to substantial orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.7k | 9/19/25 |